The European Commission (EC) has granted marketing authorisation to BridgeBio Pharma’s selective small molecule, acoramidis, ...

The EU is the second market for the drug after the US, where it was approved under the Attruby brand name last November, on ...

Nearly 3 months after the FDA green-lit the TTR stabilizer, it joins tafamidis as the second therapy in Europe for the ...

Scotiabank analyst Greg Harrison raised the firm’s price target on BridgeBio (BBIO) to $49 from $48 and keeps an Outperform rating on the ...

Bloom is an international name. Olympic skills, engaging personality and sharp business acumen have taken him all over the world ...

February is often celebrated as the month of love, but it's also recognized as American Heart Month, to raise awareness about cardiovascular health.

Shares of BridgeBio Pharma (NASDAQ:BBIO), currently valued at $5.88 billion, witnessed an uptick as Scotiabank (TSX:BNS) analyst Greg Harrison increased the price target to $49 from $48 while ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Prothena (NASDAQ:PRTA – Get Free Report) and KALA BIO (NASDAQ:KALA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses ...

Susan Lee Trentham Tupper, 67, of Rockwood, Tennessee, formerly of Clinton, passed away on Tuesday, February 11, 2025, at ...

PALO ALTO, CA, USA I 11, 2025 I BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused ...